Lori Lyons-Williams - 30 Jan 2026 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Reporting relationship: Director
Issuer ticker: RAPT
Reported as of: 30 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2026, 17:47:51 UTC
Prior SEC filing: 26 Jun 2025
Next SEC filing: 05 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Rodney Young, Attorney-in-Fact

Key filing fact

Lori Lyons-Williams filed Form 4 for RAPT Therapeutics, Inc. (RAPT) on 02 Feb 2026.

Key facts

This page summarizes Lori Lyons-Williams's Form 4 filing for RAPT Therapeutics, Inc. (RAPT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Feb 2026, 17:47.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001693564 Primary reporting owner

Lyons-Williams Lori

Relationship: Director
Address: C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE, SOUTH SAN FRANCISCO
Signature: /s/ Rodney Young, Attorney-in-Fact
Signature date: 02 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RAPT transaction

Common Stock

Award

Transaction value: $0
Shares: +4,956
Change %
Price: $0.000000
Shares after: 4,956
Date: 30 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the annual grant of restricted stock units ("RSUs") under the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as currently in effect, which fully vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock upon vesting.